Volume 27, Issue 4 e14506
ORIGINAL ARTICLE

A quality improvement intervention to decrease the decline in renal function in pediatric liver transplant recipients

Irini Batsis

Corresponding Author

Irini Batsis

Division of Hepatology, Mount Sinai Kravis Children's Hospital, New York, New York, USA

Correspondence

Irini Batsis, The Mount Sinai Hospital, One Gustave L. Levy Place, Box 1104, New York, NY 10029, USA.

Email: [email protected]

Search for more papers by this author
Scott Elisofon

Scott Elisofon

Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA

Search for more papers by this author
Michael Ferguson

Michael Ferguson

Division of Pediatric Nephrology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA

Search for more papers by this author
Maureen Jonas

Maureen Jonas

Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA

Search for more papers by this author
Brendan Kimball

Brendan Kimball

Department of Quality Improvement, Pediatric Transplant Center, Boston Children's Hospital, Boston, Massachusetts, USA

Search for more papers by this author
Christine Lee

Christine Lee

Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA

Search for more papers by this author
Paul Mitchell

Paul Mitchell

Institutional Centers for Clinical and Translational Research, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA

Search for more papers by this author
Rima Fawaz

Rima Fawaz

Division of Gastroenterology, Hepatology and Nutrition, Yale New Haven Children's Hospital, New Haven, Connecticut, USA

Search for more papers by this author
First published: 20 March 2023

Abstract

Background

Chronic kidney disease (CKD) impacts long-term morbidity in pediatric liver transplant (LT) recipients. The prevalence of estimated glomerular filtration rate (eGFR) < 90 mL/min/1.73 m2 (eGFR < 90) at our institution was 25% at 1 year post-LT; thus, quality improvement (QI) project was initiated, aiming to decrease the prevalence of eGFR < 90 by at least 20% at 1 year-post LT.

Methods

Children post-LT under 19 years from 2010 to 2018 were included. Three QI interventions were implemented starting 1/2016: documentation of blood pressure percentile (BP%) and eGFR, documentation of a kidney management plan if either was abnormal, and amlodipine initiation prior to hospital discharge after LT. We compared the prevalence of eGFR < 90 at 3, 12, and 24 months after LT in the pre- and post-intervention period.

Results

68 patients in pre- and 42 in post-intervention periods met inclusion criteria. Pre-intervention BP%, eGFR, and kidney management plan were documented at 25%, 10%, and 22%, compared to 71%, 83%, and 71% post-intervention, respectively. 22% of patients were started on amlodipine prior to discharge from LT in the pre- versus 74% in the post-intervention period. Prevalence of eGFR < 90 at 3 m post-LT was 19% in pre- versus 14% in the post-intervention period (p = .31); at 12 months 24% versus 7% (p = .01) and at 24 months 16% versus 6% (p = .13), respectively. Significant non-modifiable risk factors for eGFR < 90 were malignancy (RR = 4.5, p < .0001), metabolic disorder (RR = 2.6, p = .02), and age at transplant (7% increased risk per year of age, p = .007).

Conclusion

By improving documentation of BP%, eGFR, and kidney management plan, the prevalence of eGFR < 90 was decreased by a relative 74% and 60% at 12 and 24 months post-LT, respectively.

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available from the corresponding author upon reasonable request

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.